SYNJ2 and cancer: In addition, elevated SYNJ2 expression was associated with the unfavorable prognosis (at least one of OS, DSS, DFI, and PFI) of cancers with ACC, BRCA, GBM, KICH, KIRP, LGG, LIHC, LUAD, LUSC, MESO, PCPG, and UVM, while it represented favorable OS and DSS of THYM patients.